HEDGEHOG PATHWAY INHIBITION FOR TREATMENT OF HIGH-RISK BASAL CELL CARCINOMA OR HIGH-RISK BASAL CELL CARCINOMA NEVUS SYNDROME

• 收藏
• 分享

专利权人:

HEDGEPATH PHARMACEUTICALS; INC.

发明人:

NICHOLAS J. VIRCA

申请号：

US16425992

公开号：

US20190365743A1

申请日:

2019.05.30

申请国别(地区):

US

年份:

2019

代理人:

摘要：

The present invention concerns methods for treating high-risk basal cell carcinoma (BCC) or high-risk basal cell carcinoma nevus syndrome (BCCNS) in a subject, comprising administering a composition comprising an azole inhibitor of the Hedgehog signaling pathway (azole inhibitor) to the subject.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/